medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (3)


Cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome

González-Moreno EI, Cámara-Lemarroy CR, Borjas-Almaguer DO, Martínez-Cabriales SA, Paz-Delgadillo J, Gutiérrez-Udave R, Ayala-Cortés AS, Ocampo-Candiani J, Cortéz-Hernández CA, Maldonado-Garza HJ

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 416-419
Archivo PDF: 84.80 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Borowicz J, Gillespie M, Miller R. Cutaneous amyloidosis. Skinmed 2011; 9: 96-100; quiz 1.

  2. Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder J, Babilas P. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol 2010; 20: 152-60.

  3. Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008; 14: 3368- 73.

  4. Durazzo M, Premoli A, Paschetta E, Belci P, Spandre M, Bo S. Overlap syndromes of autoimmune hepatitis: an open question. Dig Dis Sci 2013; 58: 344-8.

  5. Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, et al. Al amyloidosis. Orphanet J Rare Dis 2012; 7: 54.

  6. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924-33.

  7. Erbagci Z, Erkilic S, Tuncel AA. Diffuse biphasic cutaneous amyloidosis in an HCV-seropositive patient: another extrahepatic manifestation of HCV infection? Int J Clin Pract 2005; 59: 983-5.

  8. Abe M, Kawakami Y, Oyama N, Nakamura-Wakatsuki T, Yamamoto T. A rare co-occurrence of primary localized cutaneous amyloidosis and chronic C type hepatitis. Int J Dermatol 2010; 49: 960-2.

  9. Saha A, Theis JD, Vrana JA, Dubey NK, Batra VV, Sethi S. AA amyloidosis associated with hepatitis B. Nephrol Dial Transplant 2011; 26: 2407-12.

  10. Ueno M, Yamamoto T, Yamanaka M, Matsunaga T. Nodular amyloidosis in a patient with liver cirrhosis. Dermatol Online J 2011; 17: 10.

  11. Rodriguez-Luna H, Vargas HE, Williams J, De Petris G, Rakela J, Douglas DD. Primary biliary cirrhosis and systemic amyloidosis, a new association. Dig Dis Sci 2004; 49: 1196-200.

  12. Parkash O, Almas A. Primary billiary cirrhosis (antimitochondrial antibody negative) leading to secondary amyloidosis. J Coll Physicians Surg Pak 2012; 22: 330-2.

  13. Kato T, Komori A, Bae SK, Migita K, Ito M, Motoyoshi Y, Abiru S, et al. Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis. World J Gastroenterol 2012; 18: 192-6.

  14. Van Steenbergen W, Braeye L, Harlet R, Nevens F, Fevery J, Desmet V, Roskams S, et al. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regres419 Cutaneous amyloidosis associated with AIH-PBC overlap syndrome. , 2015; 14 (3): 416-419 sion of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol 2010; 22: 1265-70.

  15. Tafarel JR, Lemos LB, Oliveira PM, Lanzoni VP, Ferraz ML. Cutaneous amyloidosis associated with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2007; 19: 603-5.

  16. Dahdah MJ, Kurban M, Kibbi AG, Ghosn S. Primary localized cutaneous amyloidosis: a sign of immune dysregulation? Int J Dermatol 2009; 48: 419-21.

  17. Schwendiman MN, Beachkofsky TM, Wisco OJ, Owens NM, Hodson DS. Primary cutaneous nodular amyloidosis: case report and review of the literature. Cutis 2009; 84: 87-92.

  18. Kikuchi N, Sakai E, Nishibu A, Ohtsuka M, Yamamoto T. Primary localized cutaneous amyloidosis in patients with scleroderma. Acta Derm Venereol 2010; 90: 326-7.

  19. Yamamoto T, Suzuki Y. Primary localized cutaneous amyloidosis intermingled with papulopustular lesions in a patient with Behcet’s disease. Rheumatol Int 2012; 32: 3651-3.

  20. Kamada N, Yoneyama K, Togawa Y, Suehiro K, Shinkai H, Yokota M, Matsuda K, et al. Toxic epidermal necrolysis with severe hyperbilirubinemia: complete re-epithelialization after bilirubin reduction therapies. J Dermatol 2010; 37: 534-6.

  21. Washington MK. Autoimmune liver disease: overlap and outliers. Mod Pathol 2007; 20(Suppl. 1): S15-S30.

  22. Montano-Loza AJ, Lalor E, Mason AL. Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol 2008; 22: 840-6.

  23. Cabibi D, Tarantino G, Barbaria F, Campione M, Craxi A, Di Marco V. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis 2010; 42: 585-92.




2020     |     www.medigraphic.com